Targeting transcription factors through an IMiD independent zinc finger domain
Open Access
- 14 May 2025
- journal article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (6) , 1393-1416
Abstract
Immunomodulatory imide drugs (IMiDs) degrade specific C2H2 zinc finger degrons in transcription factors, making them effective against certain cancers. SALL4, a cancer driver, contains seven C2H2 zinc fingers in three clusters, including an IMiD degron in zinc finger cluster one (ZFC1). Surprisingly, IMiDs do not inhibit the growth of SALL4-expressing cancer cells. To overcome this limit, we focused on a non-IMiD domain, SALL4 zinc finger cluster four (ZFC4). By combining ZFC4-DNA crystal structure and an in silico docking algorithm, in conjunction with cell viability assays, we screened several chemical libraries against a potentially druggable binding pocket, leading to the discovery of SH6, a compound that selectively targets SALL4-expressing cancer cells. Mechanistic studies revealed that SH6 degrades SALL4 protein through the CUL4A/CRBN pathway, while deletion of ZFC4 abolished this activity. Moreover, SH6 treatment led to a significant 87% tumor growth inhibition of SALL4+ patient-derived xenografts and demonstrated good bioavailability in pharmacokinetic studies. In summary, these studies represent a new approach for IMiD independent drug discovery targeting C2H2 transcription factors such as SALL4 in cancer.Keywords
All Related Versions
Funding Information
- Ministry of Health -Singapore (STaR18nov-0002)
- Ministry of Education - Singapore
- National Research Foundation Singapore (CIRG21nov-0009CIRG21nov-0009)
- Foundation for the National Institutes of Health (P01HL131477-01A1)
- Foundation for the National Institutes of Health (P01 HL158688/HL/NHLBI NIH)
- Foundation for the National Institutes of Health (P30 GM124165)
- Foundation for the National Institutes of Health (S10OD021527)
- Argonne National Laboratory
- Xiu research fund
- Linde Family Foundation
- AGA/Jenzabar Research Fund
- Breast Cancer Research Foundation (24-177)
This publication has 47 references indexed in Scilit:
- An NMR Spectroscopic Method to Identify and Classify Thiol‐Trapping Agents: Revival of Michael Acceptors for Drug Discovery?Angewandte Chemie International Edition, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- Integration, scaling, space-group assignment and post-refinementActa Crystallographica Section D Structural Biology, 2010
- Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of CancerClinical Cancer Research, 2009
- SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic miceBlood, 2006
- PIPER: An FFT‐based protein docking program with pairwise potentialsProteins: Structure, Function, and Bioinformatics, 2006
- hERG potassium channels and cardiac arrhythmiaNature, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Retinoic acid (RA) and As 2 O 3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARα and PLZF-RARα oncoproteinsProceedings of the National Academy of Sciences, 2000